Table 1 Reported Cases of coexistent pulmonary hemorrhage and venous thromboembolism in patients with AAV
No. | Author | Age/Sex | Involved organ | ANCA | Presentation | Steroid (total dose) | CYC | Other agent | PLEX (N sessions) | AC | IVC filter | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Sousa et al. [7] | 48(F) | Renal, ENT | PR3-ANCA | Simultaneous PH and PE | Y(1g) | No | MMF | Y(5) | No | Y | Survived, Recurrent PE, Long term AC |
2 | Sousa et al. [7] | 19(F) | Renal, ENT | PR3-ANCA | Simultaneous PH and multiple PE’s, Upper limb DVT | Y(3g) | Y | No | No | UFH | No | Survived, Short-term AC |
3 | Sousa et al. [7] | 61(M) | Renal, ENT, CNS, Skin | MPO-ANCA | PH 2 weeks after multiple PE’s | Y(3g) | No | Rituximab, IVIG | Y(5) | LMWH | Y | Survived, Pulmonary fibrios, Short term AC |
4 | Sousa et al. [7] | 45(M) | Renal, ENT | PR3-ANCA | PH 1 week before multiple PE’s and Lower limb DVT | Y(3g) | Y | No | No | LMWH | Y | Survived, CKD stage 3, Long term AC |
5 | Dreyer et al. [8] | 31(M) | Renal | PR3-ANCA | PH 1 week after Lower limb DVT and PE | Y(1.5g) | Y | No | Y(5) | UFH | Y | Survived, Short-term AC |
6 | Our case | 14(F) | Renal, Skin | MPO-ANCA | PH 5 days after right lower limbs DVT | Y(3g) | Y | MMF | Y(5) | LMWH | N | Survived, Short-term AC |